27 results
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
28 Jun 24
Departure of Directors or Certain Officers
5:00pm
the Term of Employment in providing services hereunder, subject to any requirements or conditions as may be set forth in any expense reimbursement
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
of the accomplishment of various scientific, clinical, regulatory, and other product development objectives;
the pricing and reimbursement of our product … for an up-front Cost Reimbursement of $100,000 payable to MIRALOGX to cover the already-incurred costs associated with the patent rights. The Cost
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
or may hold certain common law trademark rights.
ARTICLE 2—COSTS, ROYALTY PAYMENTS AND REPORTS
2.1 Cost Reimbursement. Licensee shall pay … to the preparation, filing, and prosecution of Patent Rights, which comments and suggestions will be considered by the other party.
6.2 Reimbursement of Prosecution
10-Q
id5t2aq588 fi0yji
15 Sep 23
Quarterly report
4:45pm
8-K
EX-1.1
xsd saldy2f9wqp6
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
424B4
1ycfyw8
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
xx023ml
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-10.9
wedpjd
29 Jun 23
IPO registration
4:39pm
S-1
vrbn9 rriu
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.8
zr0it3p
29 Jun 23
IPO registration
4:39pm
S-1
EX-10.7
5k05t7
29 Jun 23
IPO registration
4:39pm
S-1
EX-14.1
peavm1 f9
29 Jun 23
IPO registration
4:39pm